Clinical Trial: Safety and Tolerability of IBI355 in Healthy Volunteers

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06416787) titled 'Safety and Tolerability of IBI355 in Healthy Volunteers' on May 11.

Brief Summary: This study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of IBI355 in Healthy voluteers. This study also aims to evaluate the anti-Drug antibody after multiple ascending doses of IBI355 in Healthy voluteers.

Study Type: Interventional

Condition: Healthy

Intervention: * Drug: placebo

IBI355 7.5mg/kg Q4W

* Drug: IBI355

IBI355 1mg/kg Q4W

Recruitment Status: Not Yet Recruiting

Published by HT Digital Content Services with permission from Health Daily Digest....